BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, supplying promising progress across various health-related and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, much more dependable alternate for therapeutic use,